Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.850
-0.090 (-4.64%)
At close: Apr 2, 2026, 4:00 PM EDT
1.950
+0.100 (5.41%)
After-hours: Apr 2, 2026, 7:56 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $78.15 million as of April 2, 2026. Its market cap has increased by 19.28% in one year.
Market Cap
78.15M
Enterprise Value
58.04M
1-Year Change
19.28%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $78.15M, a decrease of -37.30%. That is a compound annual growth rate of -8.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 78.15M | -36.90% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 83.04M |
| NeurAxis | 81.11M |
| Fortress Biotech | 80.70M |
| MAIA Biotechnology | 80.69M |
| Champions Oncology | 80.13M |
| Grace Therapeutics | 79.38M |
| Inovio Pharmaceuticals | 78.07M |
| Cognition Therapeutics | 77.56M |